GOVERNMENT SHUTDOWN: The House Rules Committee is meeting today about setting up a floor vote on the government funding ...

The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

The FDA grants Fast Track designation to BNT113 for treating HPV16+ head and neck squamous cell carcinoma expressing PD-L1 in the first-line setting.

A gallery of MedTech components and solutions on display at the annual Medical Design & Manufacturing (MD&M) show in Anaheim.

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing ...

Insurer on using cloud-native platforms, AI workbenches and joint ownership models to scale from start-up to nearly $1 ...

MINSK, 27 January (BelTA) - Belarus and China are dynamically increasing their mutual trade, Ambassador Extraordinary and ...

Future Made in Australia is an industrial strategy to create competitive advantage, build economic resilience, deliver the ...

South Korea will expand its exchange-traded funds lineup to include single-stock leveraged products as regulators seek to ...

FDA delayed fast-track reviews for multiple drugs after safety and efficacy concerns, including adverse events and a reported patient death.

The QIDP designation will ensure at least 10 years of market exclusivity for SCY-247 following approvalRecent articles highlight the growing ...

German biotech BioNTech today announced that the US Food and Drug Administration (FDA) has granted fast track designation to ...